Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette–Guérin immunotherapy?-Reference-Cited by-同舟云学术

Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette–Guérin immunotherapy?

Published:2016-06-09 Issue:2 Volume:35 Page:237-243
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Golabek Thomasz,Palou Joan,Rodríguez Oscar,Gaya Josep Maria,Breda Alberto,Villavicencio Humberto

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-016-1856-9.pdf

Reference39 articles.

1. Denzinger S, Fritsche HM, Otto W, Blana A, Wieland WF, Burger M (2008) Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach? Eur Urol 53(1):146–152

2. Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Compérat E, Sylvester RJ, Kaasinen E, Böhle A, Redorta JP, Rouprêt M (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64(4):639–653

3. Shahin O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE (2003) A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette–Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 169(1):96–100

4. Günlüsoy B, Değirmenci T, Arslan M, Nergiz N, Minareci S, Ayder AR (2005) Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette–Guérin. Urol Int 75(2):107–113

5. Emiliozzi P, Pansadoro A, Pansadoro V (2008) The optimal management of T1G3 bladder cancer. BJU Int. 102(9 Pt B):1265–1273

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of multiparametric magnetic resonance ımaging in the diagnosis of granulomatous prostatitis mimicking prostate cancer;Abdominal Radiology;2024-04-23

2. Long-term Recurrence and Progression Patterns in a Contemporary Series of Patients with Carcinoma In Situ of the Bladder With or Without Associated Ta/T1 Disease Treated with Bacillus Calmette-Guérin: Implications for Risk-adapted Follow-up;European Urology Focus;2023-03

3. Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective;Frontiers in Oncology;2023-01-31

4. Late recurrence in patients with non‐muscle‐invasive bladder cancer after 5‐year cancer‐free periods;International Journal of Urology;2022-05-21

5. Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR);ClinicoEconomics and Outcomes Research;2022-01